SK Bioscience

Novavax, SK Bioscience, Covid 19, Vaccine

SK Bioscience invests $85M on a 7% share in the vaccine manufacturer, Novavax, to keep it afloat

SG Tylor

Following its setback during the pandemic phase of COVID-19 with a delayed vaccine, Novavax is now aiming for recovery in ...